Access to Medicine & Social Impact in Pharma

A focused exam on access to medicine and pharma social impact. Covers affordability and pricing, generics and biosimilars, compulsory and voluntary licensing, the Medicines Patent Pool, neglected diseases R&D, equitable distribution, the Access to Medicine Index, and India's role in global access. For pharma, public-health, and social-impact professionals.